Secondary thrombocythemia
Secondary thrombocythemia is mainly seen in chronic infection, malignant tumors, acute blood loss, hemolytic anemia, reaction to surgical drugs and connective tissue disease leading to excessive platelet production. It is generally asymptomatic, but some patients may have thrombosis. It can be diagnosed when the peripheral platelet count is higher than normal>400×109/L.
-
Site of disease:
Blood vessels -
Infectious :
Not contagious -
Frequent population:
Secondary to the original underlying disease -
Related symptoms:
Atherosclerosis Thrombocytosis Hyperviscosity syndrome Erythrocytosis-hyperviscosity Abnormal blood count -
Concurrent disease:
Related Drugs
Aspirin Dipyridamole Sustained Release Capsules
Indication: This product is suitable for reducing the risk of occurrence or recurrence of stroke in patients who have suffered transient ischemic attack or ischemic stroke caused by cerebral thrombosis.
Manufacturer:
Penglai Nuokang Pharmaceutical Co., Ltd.
Dipyridamole injection
Indication: A test of a drug used to diagnose myocardial ischemia.
Manufacturer:
Yabao Pharmaceutical Group Co., Ltd.
Heparin Sodium Injection
Indication: Used to prevent and treat thrombosis or embolic diseases (such as myocardial infarction, thrombophlebitis, pulmonary embolism, etc.); disseminated intravascular coagulation (DIC) caused by various reasons; also used in hemodialysis, extracorporeal circulation, catheterization, microvascular surgery and other operations and for anticoagulation of certain blood specimens or instruments.
Manufacturer:
Nanjing Xinbai Pharmaceutical Co., Ltd.
Related Ingredients